Yu S, Yan C, Wu W, He S, Liu M, Liu J, et al. RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion. Front Pharmacol. 2019;10:1296 pubmed publisher

Habel N, Stefanovska B, Carène D, Patino Garcia A, Lecanda F, Fromigue O. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process. BMC Cancer. 2019;19:62 pubmed publisher

Gao L, Fan Y, Hao Y, Yuan P, Liu D, Jing Z, et al. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells. Int J Med Sci. 2017;14:820-828 pubmed publisher

Yu Y, Prassas I, Dimitromanolakis A, Diamandis E. Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics. J Biol Chem. 2015;290:17762-75 pubmed publisher

Zhou F, Zhang Y, Chen D, Su Z, Jin L, Wang L, et al. Potential role of Cyr61 induced degeneration of human Müller cells in diabetic retinopathy. PLoS ONE. 2014;9:e109418 pubmed publisher

Thorne A, Meisen W, Russell L, Yoo J, Bolyard C, Lathia J, et al. Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. Mol Ther. 2014;22:1678-87 pubmed publisher

Brigstock D. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis. 2002;5:153-65 pubmed

Menendez J, Mehmi I, Griggs D, Lupu R. The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. Endocr Relat Cancer. 2003;10:141-52 pubmed